Skip to content

Effectiveness and Safety Study of Peripheral Balloon Dilatation Catheter in Percutaneous Transluminal Angioplasty(PTA) Procedure

A Prospective, Multicenter and Single-arm Target Value Clinical Study on the Efficacy and Safety of Peripheral Balloon Dilatation Catheter in PTA Procedure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01849601
Enrollment
167
Registered
2013-05-08
Start date
2012-12-31
Completion date
2013-03-31
Last updated
2015-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Arterial Disease

Brief summary

The purpose of this study is to determine whether the peripheral balloon dilatation catheter (trade name: Iris) is safe an effective in PTA procedure.

Interventions

DEVICEpercutaneous transluminal angioplasty balloon catheter

Sponsors

Acotec Scientific Co., Ltd
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age: 18 yrs - 80 yrs. * patients with iliac and / or femoral artery atherosclerotic lesions * Rutherford grade of 1-5; * Target lesion stenosis≥70% (visual estimation) (proportion of Trans-Atlantic Inter-Society Consensus(TASC) B, C and D grade lesions not less than 60% ) * Patients being able to understand the purpose of the test, and being volunteered to participate in and sign the informed consent.

Exclusion criteria

* Patients not suitable for receiving interventional surgeries of lower limb arteries for treatment; * Patients require intervention of lesions besides unilateral iliac and femoral artery lesions at the same time; * Patients have been involved in clinical trials of other drugs or medical devices within the past three months; * Patient is unable or unwilling to participate in this trial; * Patients with serious heart and brain, liver and other vital organs failure; * Patients with life expectancy less than 6 months; * Pregnant women.

Design outcomes

Primary

MeasureTime frameDescription
technical success rate of PTA procedureinstant1. successfully pass lesion(s) 2. successfully dilate lesion(s)( diameter of balloon reach at least 90% of the nominal diameter) 3. successfully retrieve The definition of technical success rate of PTA procedure is that, all of the above 3 point are successful

Secondary

MeasureTime frameDescription
safety assessmentday 2 to day 10 after procedure or hospital discharge1. relevant balloon complications occurred during procedure(failure of balloon inflation, rupture of the balloon, failure of balloon deflation, failure of withdrawn, catheter fracture, etc.). 2. Relevant major vascular complications occurred during procedure (rupture of blood vessels and acute vascular occlusion caused by dilation).

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026